Saleh Bhar

Saleh Bhar, MD, is an Assistant Professor in the Department of Pediatrics at Baylor College of Medicine, with clinical and research affiliations at Texas Children’s Hospital. He specializes in Pediatric Hematology-Oncology and Critical Care Medicine, with a focus on bone marrow and stem cell transplantation, cell and gene therapy, and critical care management of complex pediatric patients.

• Institution: Baylor College of Medicine
• Department: Department of Pediatrics, Section of Pediatric Hematology Oncology and Critical Care Medicine
• Location: Houston, TX
• Email: sxbhar@texaschildrens.org

Dr. Bhar completed his medical degree at Hacettepe University in Turkey, followed by residency training in Lebanon and the U.S., and advanced fellowships in Pediatric Hematology-Oncology, Bone Marrow Transplantation, and Pediatric Critical Care at Baylor College of Medicine.

His research interests include:

• Critical care management of patients undergoing hematopoietic stem cell transplantation (HSCT) and immunotherapy (e.g., CAR-T)
• Thrombosis and hemostasis in the ICU
• Medical apheresis
• Complications of cell and gene therapies
• Pediatric oncologic and hematologic emergencies

His recent publications (2023–2025) focus on ICU resource utilization post-CAR-T therapy, transplant-associated thrombotic microangiopathy, cerebral sinus venous thrombosis in leukemia, pulmonary complications post-HSCT, and management of rare conditions like hyperhemolysis syndrome and VOD/SOS. These works reflect a strong emphasis on translational research, multicenter collaboration, and improving outcomes in critically ill pediatric hematology-oncology patients.

He has received notable scientific awards:

• 2023: Faculty Recognition Award for Excellence in Teaching, Texas Children’s Cancer and Hematology Center
• 2022: Early Career Faculty Award for Excellence in Clinical Care, Baylor College of Medicine

Dr. Bhar is actively involved in clinical care, research, and teaching. He serves on multiple professional societies, including the American Society of Hematology (ASH), American Society for Transplantation and Cellular Therapy (ASTCT), and Society of Critical Care Medicine (SCCM). His work is supported by institutional affiliations with the Texas Children’s Cancer and Hematology Centers and the Center for Cell and Gene Therapy. He has no known lab or team named explicitly, but collaborates extensively with multidisciplinary teams in pediatric critical care and transplantation.